TitelSymptom monitoring with patient-reported outcomes using a web application among lung cancer patients in the Netherlands (SYMPRO-LUNG )
- Conditions
- Lung cancerLung carcinoma1002765610029107
- Registration Number
- NL-OMON50136
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 584
Cytological or histologically proven or radiological suspect small or non-small
cell lung cancer patients that are starting treatment with radiotherapy,
surgery, chemotherapy, immunotherapy or targeted therapy, or a combination.
Other inclusion criteria are 18 years and older, ECOG Performance Status
classification should be 0,1 or 2 and access to internet.
Patients who are participants of a treatment study or when their life
expectancy at moment of inclusion is shorter than 15 weeks. The patient*s
treatment and follow up will have to remain in an affiliated hospital
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome is to measure the difference in QoL (EORTC QLQ C30 score),<br /><br>15 weeks after the start of the treatment.</p><br>
- Secondary Outcome Measures
Name Time Method